1 – 10 of 29
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Tailoring degradable starch microsphere properties through predictive modelling
(
- Master (Two yrs)
-
Mark
Towards the synthesis of a CNS-active galectin-3 inhibitor in the form of a galactopyranose-depleted variant of a macrocyclic drug lead.
(
- Master (Two yrs)
-
Mark
Towards the synthesis of small non-carbohydrate mimics of Galectin-3 inhibitors for CNS diseases.
(
- Master (Two yrs)
-
Mark
Data-driven investigations into the reactivity and selectivity of thianthrenation-based C–H functionalization
(
- Master (Two yrs)
-
Mark
Discovery of Novel Small Molecule Aquaporin-3 Inhibitors
(
- Master (Two yrs)
-
Mark
Towards Sustainable Manufacturing of Preterm Labor Treatment Drug Atosiban
(
- Master (Two yrs)
-
Mark
Electrophilic aromatic substitution on hetero arenes in buffer
(
- Master (Two yrs)
-
Mark
Discovery of novel AQP3-inhibitors
(
- Master (Two yrs)
-
Mark
Design and Synthesis of Sialic Acid Derivatives - the Potential of 7-ethers as Bacterial Inhibitors
(
- Master (Two yrs)
-
Mark
Design and synthesis towards a non-carbohydrate galectin-1 inhibitor for potential treatment of CNS diseases
(
- Master (Two yrs)